The safety profile of azithromycin in pediatrics: a pharmacovigilance disproportionality analysis

These findings provide crucial insights into the ADE profile of azithromycin in pediatric patients, supporting enhanced clinical vigilance and risk identification efforts. This study underscores the importance of monitoring both common and rare ADEs to ensure safer azithromycin use in children.